Stock Earnings

Question 1

Terns Pharmaceuticals Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Terns Pharmaceuticals Inc'in toplam varlıkları $363 olup, net loss $-88'dir.

Question 2

TERN'ün temel finansal oranları nelerdir?

Accepted Answer

Terns Pharmaceuticals Inc'in cari oranı 20.16, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Terns Pharmaceuticals Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Currently Terns Pharmaceuticals Inc data is not available.

Question 4

Terns Pharmaceuticals Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Terns Pharmaceuticals Inc'in net loss $-88'dir.

Question 5

Terns Pharmaceuticals Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Terns Pharmaceuticals Inc'in yükümlülüğü 18'dir.

Question 6

Terns Pharmaceuticals Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Terns Pharmaceuticals Inc'in toplam tedavüldeki hisse sayısı 87.12'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	1	0
Revenue Growth (YoY)	--	--	--	-100%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	33	31	39	22	19	9
Research & Development	72	70	63	39	31	28
Operating Expenses	105	101	102	62	50	37
Other Non Operating Income (Expenses)	0	0	0	0	0	-2
Pretax Income	-91	-88	-89	-59	-49	-39
Income Tax Expense	0	0	0	0	0	0
Net Income	-91	-88	-90	-60	-50	-29
Net Income Growth	-5%	-2%	50%	20%	72%	-56.99%
Shares Outstanding (Diluted)	91.57	79.5	71.25	36.03	22.71	22.72
Shares Change (YoY)	24%	12%	98%	59%	0%	0%
EPS (Diluted)	-1	-1.11	-1.26	-1.67	-2.21	-1.29
EPS Growth	-22%	-12%	-24%	-24%	71%	-56.99%
Free Cash Flow	-74	-70	-67	-49	-42	-30
Free Cash Flow Per Share	-0.8	-0.88	-0.94	-1.35	-1.84	-1.32
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	-4,900%	0%
Profit Margin	0%	0%	0%	0%	-5,000%	0%
Free Cash Flow Margin	0%	0%	0%	0%	-4,200%	0%
EBITDA	-105	-101	-102	-62	-49	-37
EBITDA Margin	0%	0%	0%	0%	-4,900%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-105	-101	-102	-62	-49	-37
EBIT Margin	0%	0%	0%	0%	-4,900%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Terns Pharmaceuticals Inc (TERN) Price